# An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Source: https://onco.cc/trials/nct05876754/  
OnCo record `nct05876754` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Ivosidenib in biliary tract cancer, run by Servier Affaires Médicales, active and no longer recruiting.

## Summary

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma is a phase 3 interventional study registered as NCT05876754 by Servier Affaires Médicales, with 299 participants enrolled, started 2023-05-03 and due to reach its primary completion in 2027-12-01. Interventions recorded: Ivosidenib Oral Tablet.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05876754
- Phase: 3
- Setting: An Open-Label Early Access Phase 3b Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
- Sponsor: Servier Affaires Médicales
- Enrolled: 299

## Sources

- ClinicalTrials.gov NCT05876754: https://clinicaltrials.gov/study/NCT05876754

## Connected records

- cancers: [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/)
- drugs: [Ivosidenib](https://onco.cc/drugs/ivosidenib/)

---
JSON: https://onco.cc/api/v1/entities/nct05876754.json